Project/ Programme Manager 12 month FTC

Workplace
On-site
Employment
Fractional

About this role

 
 

Join Us in Changing Lives 

 

At OXB, our people are at the heart of everything we do. We’re on a mission to enable life-changing therapies to reach patients around the world—and we’re looking for passionate individuals who embody our core values every day: Responsible, Responsive, Resilient, and Respectful. 

 

We’re currently recruiting for a Project/Programme Manager to join our Commercial team on a 12-month fixed-term contract. In this role, you will be managing the relationship between OXB and its Clients and ensure projects are delivered on time and within budget to the required quality to ensure successful long-term alliances, playing a key role in advancing our mission and making a real difference. 

 

Your responsibilities in this role would be to: 

  • Maintain client / partner satisfaction to ensure successful long-term alliances. 

  • Understand client needs and identifies ongoing project opportunities. 

  • Ensure projects are delivered within the agreed scope, timeline and budget and project milestones are met. 

  • Ensure project risks are identified, and effective mitigation actions are put in place. 

  • Provide project updates and performance data to OXB Management to enable effective strategic and tactical decision making. 

  • Be responsible for all financial aspects of the collaboration including forecasting, cost control and invoicing etc. 

  • Determine scope, costings, and timelines for new work packages. 

  • Assist with preparing proposals and contributes to contract negotiations for prospective clients. 

 

We are looking for: 

  • Scientific Degree or PhD. 

  • Project Management qualification preferred. 

  • Demonstrable experience using Project Management tools, methodologies & techniques. 

  • Significant project management experience inclusive of budgetary ownership, preferably within the pharmaceutical /biotech industry. 

  • Good technical understanding of biopharmaceutical process development and GMP manufacturing. 

  • Experience of working to external client deliverables. 

  • Line management experience preferred but not essential. 

  • Experience of managing projects using MS Project & MS Excel. 

 

About Us: 

OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.  

One of the original pioneers in cell and gene therapy, OXB has 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB’s world-class capabilities range from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.  

OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVecta™ system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines.  

OXB, a FTSE250 and FTSE4Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US.  

 

Why Join Us?  

💸 Competitive total reward packages  

🧘 Wellbeing programs that support your mental and physical health  

🚀 Career development opportunities to help you grow and thrive  

🤝 Supportive, inclusive, and collaborative culture  

🧪 State-of-the-art labs and manufacturing facilities  

🌍 A company that lives its values: Responsible, Responsive, Resilient, Respect  

 

We want you to feel inspired every day. At OXB, we’re future-focused and growing fast. We succeed together—through passion, commitment, and teamwork.  

 

Ready to Make a Difference?  

 

The closing date for applications is Friday 13th November 2026. 

Please note: Our vacancies are typically advertised for a minimum of 10 working days. Once a vacancy closes, it may take a few days for us to provide an update while our Talent Acquisition team and Hiring managers review all applications. 

Every application is reviewed manually by our recruitment team and hiring managers. We do not use AI to screen CVs or make shortlisting decisions. 

Apply to OXB

Clera fills in OXB's application for you.

How it works

Open the role in Clera

Sign in, and this role opens on your Clera job board, ready to apply.

Clera fills in the application

Clera fills the form from your profile and resume, and asks what's missing.

Track it in Clera

Each application you send shows up in your Clera tracker, sorted by stage.

Want Clera to find roles for you?

Ask your AI about this role

It knows you. Clera gives it the role.

Does this role fit my profile?

First time? Connect Clera once, about a minute.
One click above pre-fills the connector. Or by hand: Settings > Connectors > Add custom connector, paste https://mcp.getclera.com. Either way, sign in with the account you use on Clera and approve the consent screen.
https://mcp.getclera.com

Sign in with your Clera account. MCP docs

About OXB

OXB (LSE: OXB) is a global quality and innovation-led contract development and manufacturing organisation (CDMO) in cell and gene therapy with a mission to enable its clients to deliver life changing therapies to patients around the world.

One of the original pioneers in cell and gene therapy, OXB has over 30 years of experience in viral vectors; the driving force behind the majority of cell and gene therapies. OXB collaborates with some of the world’s most innovative pharmaceutical and biotechnology companies, providing viral vector development and manufacturing expertise in lentivirus, adeno-associated virus (AAV), adenovirus and other viral vector types. OXB’s world-class capabilities range from early-stage development to commercialisation. These capabilities are supported by robust quality-assurance systems, analytical methods and depth of regulatory expertise.

OXB offers a vast number of technologies for viral vector manufacturing, including a 4th generation lentiviral vector system (the TetraVecta™ system), a dual-plasmid system for AAV production, suspension and perfusion process using process enhancers and stable producer and packaging cell lines.

OXB, a FTSE250 and FTSE4Good constituent, is headquartered in Oxford, UK. It has development and manufacturing facilities across Oxfordshire, UK, Lyon and Strasbourg, France, Bedford MA, and Durham NC, US. Learn more at www.oxb.com and follow us on LinkedIn and YouTube.

Team size
501-1,000 employees people
Industry
Pharmaceutical Manufacturing
Workplace
On-site
Locations
Oxford, England, United Kingdom

Benefits

  • Competitive total reward packages
  • Wellbeing programs
  • Career development opportunities
  • Supportive, inclusive, and collaborative culture